Search by Drug Name or NDC
NDC 00054-0244-25 Codeine sulfate 30 mg/1 Details
Codeine sulfate 30 mg/1
Codeine sulfate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is CODEINE SULFATE.
MedlinePlus Drug Summary
Codeine is used to relieve mild to moderate pain. It is also used, usually in combination with other medications, to reduce coughing. Codeine will help relieve symptoms but will not treat the cause of symptoms or speed recovery. Codeine belongs to a class of medications called opiate (narcotic) analgesics and to a class of medications called antitussives. When codeine is used to treat pain, it works by changing the way the brain and nervous system respond to pain. When codeine is used to reduce coughing, it works by decreasing the activity in the part of the brain that causes coughing. Codeine is also available in combination with acetaminophen (Capital and Codeine, Tylenol with Codeine), aspirin, carisoprodol, and promethazine and as an ingredient in many cough and cold medications. This monograph only includes information about the use of codeine. If you are taking a codeine combination product, be sure to read information about all the ingredients in the product you are taking and ask your doctor or pharmacist for more information.
Related Packages: 00054-0244-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Codeine
Product Information
NDC | 00054-0244 |
---|---|
Product ID | 0054-0244_98a36372-b8c6-4717-8e49-ed62329404e6 |
Associated GPIs | 65100020200310 |
GCN Sequence Number | 004186 |
GCN Sequence Number Description | codeine sulfate TABLET 30 MG ORAL |
HIC3 | H3A |
HIC3 Description | OPIOID ANALGESICS |
GCN | 16241 |
HICL Sequence Number | 001722 |
HICL Sequence Number Description | CODEINE SULFATE |
Brand/Generic | Generic |
Proprietary Name | Codeine sulfate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | codeine sulfate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 30 |
Active Ingredient Units | mg/1 |
Substance Name | CODEINE SULFATE |
Labeler Name | Hikma Pharmaceuticals USA Inc. |
Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
DEA Schedule | CII |
Marketing Category | NDA |
Application Number | NDA022402 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00054-0244-25 (00054024425)
NDC Package Code | 0054-0244-25 |
---|---|
Billing NDC | 00054024425 |
Package | 100 TABLET in 1 BOTTLE (0054-0244-25) |
Marketing Start Date | 2009-07-16 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.64921 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | CODEINE SULFATE 30 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |